Maia M B, Tufenkji A E, Rochas M A, Saivin S, Houin G
Laboratoire de Pharmacocinétique, Faculté des Sciences Pharmaceutiques, Toulouse, France.
Fundam Clin Pharmacol. 1994;8(2):178-84. doi: 10.1111/j.1472-8206.1994.tb00795.x.
In vitro mitoxantrone binding to human serum, human serum albumin (HSA, 600 microM) and alpha-1-acid glycoprotein (AAG, 15 microM) was investigated by ultrafiltration and the first-derivative spectrophotometry based on the "zero crossing" method. The binding of mitoxantrone to isolated proteins was studied at eight concentrations whose range depended on the protein used. The results showed that mitoxantrone binding to human plasma and HSA involved a saturable binding. The AAG binding involved a saturable binding followed by a non saturable process. Within the concentration range studied, the percent and binding parameters which characterize the drug-protein interaction were comparable in both methods.
通过超滤和基于“零交叉”法的一阶分光光度法研究了米托蒽醌在体外与人血清、人血清白蛋白(HSA,600微摩尔)和α-1-酸性糖蛋白(AAG,15微摩尔)的结合情况。在八个浓度下研究了米托蒽醌与分离蛋白的结合,浓度范围取决于所用的蛋白。结果表明,米托蒽醌与人血浆和HSA的结合涉及饱和结合。AAG的结合涉及一个饱和结合过程,随后是一个不饱和过程。在所研究的浓度范围内,两种方法中表征药物-蛋白质相互作用的百分比和结合参数具有可比性。